Bristol Myers Says Cell Therapy Shows Promise For Heavily Pretreated Blood Cancer Patients

기사 요약

Bristol Myers Squibb reported positive Phase 2 results for its arlo-cel therapy, meeting key endpoints for multiple myeloma patients.